Datapoint

Datapoint: Centene Takes on Major Medicare Expansion for 2022

Centene Corp. on Oct. 4 said it will expand its Medicare Advantage market’s geographic footprint by 26% in 2021, offering products in 1,575 counties across 36 states. Centene currently serves 1,208,486 M...
0 Comments

Datapoint: Humana Unveils 2022 MA Plans

Humana Inc. will offer 72 new Medicare Advantage plans in the 2022 plan year, expanding to “hundreds” of new counties according to an Oct. 1 press release from the insurer. The insurer has enhanced its b...
0 Comments

Datapoint: FDA Approves AbbVie’s Qulipta in Migraine Prevention

The FDA on Sept. 28 approved AbbVie’s CGRP inhibitor Qulipta for the prevention of episodic migraine, with analysts already calling the drug a blockbuster-to-be. Qulipta will have to face off against Biohav...
0 Comments

Datapoint: Aetna Plots 2022 Medicare Expansion

CVS Health Corp.’s Aetna will expand its Medicare Advantage products to 83 new counties for the 2022 plan year, bringing its total reach to 46 states, according to an Oct. 1 press release. With this expan...
0 Comments

Datapoint: Oscar Expanding to Chicago, Miami

Oscar Health will partner with health systems in the Chicago and Miami areas to expand its individual offerings to four populous counties for the 2022 plan year, according to recent press releases from the insur...
0 Comments

Datapoint: Tivdak Scores FDA Nod for Cervical Cancer

The FDA on Sept. 20 granted an accelerated approval to Seagen Inc. and Genmab A/S’s Tivdak for the treatment of recurrent or metastatic cervical cancer that has continued to progress following chemotherapy. The dr...
0 Comments

Datapoint: Florida Blue, Baptist Health Launch New Group HMO

Florida Blue and Baptist Health Care have launched Truli for Health, a new health maintenance organization that will begin offering health insurance products for small and medium sized businesses Oct. 1. The plans...
0 Comments

Datapoint: Jakafi Approved for Chronic GVHD

The FDA last week approved Incyte Corp.’s JAK inhibitor Jakafi for the treatment of chronic graft-versus-host disease (GVHD) in patients that have not responded to one or two other lines of systemic therapy. Jak...
0 Comments

Datapoint: Intermountain, SCL Health to Merge

Two nonprofit health systems, Salt Lake City’s Intermountain Healthcare and Broomfield, C.O.-based SCL Health signed a letter of intent to merge, according to a Sept. 16 press release. The combined organization w...
0 Comments

Datapoint: Amgen Shores Up Otezla Patent Until 2028

In a victory against Sandoz and Zydus Pharmaceuticals, Amgen last week won a patent case protecting its blockbuster psoriasis drug Otezla from generic competition until 2028. For the treatment of psoriasis, Otezla...
0 Comments